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Abstract
Structural Nested Mean Models (SNMMs) are useful for causal inference of treatment effects
in longitudinal observational studies. Most of the existing methods assume that the data are
collected at pre-fixed time points for all subjects, which, however, is restrictive in practice. To
deal with irregularly-spaced observations, we assume a class of continuous-time SNMMs and a
martingale condition of no unmeasured confounding (NUC) to identify the causal parameters.
We establish the first semiparametric efficiency theory for continuous-time SNMMs. This task
is non-trivial due to the restrictions imposed on the SNMM parameter by UNC. Based on our
result, we construct locally efficient estimators, which achieve the semiparametric efficiency
bound. In the presence of dependent censoring, we propose an inverse probability of censoring
weighting estimator and show its multiple robustness.
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1 Introduction
1.1 Causal inference methods with time-varying confounding
The gold standard to draw causal inference of treatment effects is designing randomized experi-
ments. However, randomized experiments are not always feasible due to practical constraints or
ethical issues. Moreover, randomized experiments often have restrictive inclusion and exclusion
criteria for patient enrollment, which limits the experiment results to be generalized to a larger real-
world patient population. In these cases, observational data are useful. In observational studies,
confounding by indication poses a unique challenge to drawing valid causal inference of treatment
effects. For example, sicker patients are more likely to take the active treatment, whereas health-
ier patients are more likely to take the control treatment. Consequently, it is not fair to compare
the outcome from the treatment group and the control group directly. Moreover, in longitudinal
observational studies, confounding by indication is likely to be time-dependent, in the sense that
time-varying prognostic factors of the outcome affect the treatment assignment at each time, and
thereby distort the association between treatment and outcome over time. In these cases, the tradi-
tional regression methods are biased even adjusting for the time-varying confounders (Robins et al.,
1992, Hernán et al., 2000, 2005, Robins and Hernán, 2009, Orellana et al., 2010).
Parametric g-computation (Robins, 1986), Marginal Structural Models (MSMs; Robins 2000,
Hernán et al. 2001), and Structural Nested Models (SNMs; Robins et al., 1992, Robins, 1994) are
three major approaches to overcome the challenges with time-varying confounding. SNMs have prop-
erties that are more appealing than parametric g-computation and MSMs (Robins, 2000): i) SNMs
are semiparametric and gain robustness over parametric g-computation; ii) unlike MSMs, SNMs do
not use inverse probability weighting for estimation which can lead to both bias and large variabil-
ity if the positivity assumption is violated; iii) MSMs allow modeling only the baseline treatment
modification effects; in contrast, SNMs allow modeling time-varying treatment modification effects;
iv) SNMs show important applications in personalized medicine for discovery of optimal treatment
regimes that are tailored to individual’s characteristics and disease status (Chakraborty and Moodie,
2013).
1.2 Continuous-time structural nested mean models
We focus on a class of SNMs for continuous outcomes, namely, structural nested mean models (SN-
MMs). We discuss the extension to accommodate different types of outcome in Section 7. Most of
the existing work on SNMMs assume discrete-time data generating processes and require all sub-
jects to be followed at the same pre-fixed time points, such as months. The literature of discrete-
time SNMMs is fruitful; see, e.g., Robins (1998b), Robins et al. (2000), Almirall et al. (2010),
Chakraborty and Moodie (2013), Lok and DeGruttola (2012), Lok and Griner (2014), Yang and Lok
(2016, 2018). However, in practice, the observational data are often collected by user-initiated visits
to clinics, hospitals and pharmacies, and the data are more likely to be measured at irregularly-
spaced time points, which are not necessarily the same for all subjects. Such data are now com-
monplace, such as electronic health records, claims databases, disease data registries, and so on
(Chatterjee et al., 2016). The existing causal framework does not directly apply in such situations,
requiring some (possibly arbitrary) discretization of the timeline (Neugebauer et al., 2010). Such
data pre-processing is quite standard and routine to practitioners, but leads to many unresolved
problems: the treatment process depends transparently on the discretization, and therefore the in-
terpretation of SNMMs depends on the definition of time interval (Robins, 1998a). Moreover, after
discretization, the data may need to be recreated at certain time points. Consider monthly data
for example. If a subject had multiple visits within the same month, a common strategy is to take
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the average of the multiple measures as the observation for a given variable at that month. If a
subject had no visit for a given month, one may need to impute the missing observation. Because
of such distortions, the resulting data may not satisfy the standard causal consistency or no unmea-
sured confounding (NUC) assumptions. Consequently, model parameters may not have a causal
interpretation.
With irregularly spaced observations, it is more reasonable to assume that the data are gener-
ated from continuous-time processes. The work for causal models in continuous-time processes is
somewhat sparse; exceptions include e.g. Robins (1998a), Lok et al. (2004), Lok (2008), Zhang et al.
(2011), Lok (2017). Extending the existing causal models with discrete-time processes to continuous-
time processes is not trivial. An important challenge lies in time-dependent selection bias or con-
founding; e.g., in a health-related study, sicker patients may visit the doctor more frequently and
are more likely to initiate the treatment. To overcome this challenge, following Lok (2008), we treat
the observed treatment assignment process as a counting process NT (t) and assume a martingale
condition of NUC on NT (t) to identify the SNMM parameters. Specifically, the NUC assumption
entails that the jumping rate of NT (t) at t does not depend on future potential outcomes, given
the past treatment and covariate history up to t. A practical implication is that the covariate set
should be rich enough to include all predictors of outcome and treatment, so that we can distinguish
the treatment effect and the confounding effect. This assumption was also adopted in Zhang et al.
(2011) and Yang et al. (2018) to the settings where the effect of a treatment varies in continuous
time. Lok (2017) provided a strategy of constructing unbiased estimating equations exploiting the
relationship between the mimicking potential outcome process and the treatment process, which
leads to a large class of estimators. While this strategy provides unbiased estimators, there is
no guidance on how to choose an efficient estimator, and a naive choice can lead to inaccurate
estimation.
1.3 Semiparametric efficiency theory
We establish the new semiparametric efficiency theory for continuous-time SNMMs with irregularly-
spaced observations. Toward this end, we follow the geometric approach of Bickel et al. (1993) for
the semiparametric model by characterizing the nuisance tangent space, it orthogonal complemen-
tary space, and lastly the semiparametric efficiency score for the SNMM parameter.
In our problem, the SNMM and the NUC assumption constitute the semiparametric model for
the data. Given the close relationship of causal inference and missing data theory (Ding and Li,
2018), it is worthwhile to discuss the connection of the semiparametric efficiency development in
this article and that in the missing data literature. The NUC assumption for the treatment process
plays the same role of the ignorability assumption for the missing data mechanism; therefore, our
characterization of the nuisance tangent space for the treatment process follows the same as that for
the continuous-time missing data process; see Section 5.2 of Tsiatis (2006). Besides this analogy, our
theoretical task is considerably more complicated. Although the NUC assumption does not have any
testible implications on the observed-data likelihood (Van Der Laan and Dudoit, 2003, Tan, 2006),
it imposes conditional independence restrictions on the treatment process and the counterfactual
outcomes, given the past history, and hence restrictions for the SNMM parameter; see equation
(9). To circumvent this complication, we use the variable transformation technique and translate
the restrictions into the new variables, which leads to the unconstrained observed data-likelihood.
This step allows us to characterize the semiparametric efficiency score for the SNMM parameter
and construct locally efficient estimators which achieve the semiparametric efficiency bound.
To accommodate possible dependent censoring, we propose the inverse probability of cen-
soring weighting (IPCW) estimator. We show that the proposed estimator is multiply robust
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in that it is consistent if either the potential outcome mean model is correctly specified or the
model for the treatment process is correctly specified, regardless whether the censoring model
is correctly specified. This amounts to six scenarios specified in Table 1 that guarantee consis-
tent estimation, allowing some components in the union of the three models to be misspecified
(Molina et al., 2017, Wang and Tchetgen Tchetgen, 2018). Moreover, using the empirical process
theory (van der Vaart and Wellner, 1996), we characterize the asymptotic property of the proposed
estimator of the SNMM parameter under a parametric outcome mean model, and proportional
hazards models for the treatment and censoring processes, allowing for multiply robust inference.
It is important to note that for regularly spaced observations, i.e. the data process can only
take values at pre-fixed time points, the proposed estimator simplifies to the existing estimator with
discrete-time data. For irregularly spaced observations, the new model and estimation framework
allows us to deal with irregularly spaced observations directly and respects the nature of the under-
lying data generating mechanism. In contrast, the existing g-estimator requires data pre-processing
and may introduce bias as demonstrated by simulation in Section 5.
The rest of the article is organized as follows. In Section 2, we describe the SNMM with discrete-
time processes, which serves as a building block to establishing the semiparametric efficiency theory
for continuous-time processes and also enables us to establish their connection. In Section 3, we
present the semiparametric efficiency theory and locally efficient estimators for the continuous-
time SNMM under the NUC assumption. Moreover, we propose an IPCW estimator to deal with
dependent censoring due to premature dropout. In Section 4, we establish the asymptotic property
of the estimator allowing for multiply robust inference. In Section 5, we present simulation studies
to investigate the performance of the proposed estimator compared to the existing competitor in
finite samples. In Section 6, we apply the proposed estimator to estimate the effect of the time
between HIV infection and initiation of highly active antiretroviral therapy (HAART) on the CD4
count at year 2 after infection in HIV-positive patients with early and acute infection. We conclude
the article with discussions in Section 7. Major proofs are provided in Section 8.
2 Structural nested mean models in discrete-time processes
2.1 Setup, models, and assumptions
We first describe the SNMM in discrete-time processes. We assume that n subjects are followed at
pre-fixed discrete times t0 < · · · < tK+1 with t0 = 0 and tK+1 = τ . We assume that the subjects
are simple random samples from a larger population (Rubin, 1978). For simplicity, we suppress the
subscript i for subjects. Let Lm be a vector of covariates at time tm. Let Am be the treatment
indicator at tm; i.e., Am = 1 if the subject was on treatment at tm and Am = 0 otherwise. We
use the overline notation to denote a variable’s history; e.g., Am = (A0, . . . , Am). We assume that
once treatment is initiated, it is never discontinued, so each treatment regime corresponds to one
treatment initiation time. Let T be the time to treatment initiation, and let T =∞ if the subject
never initiated the treatment during the follow up. Let Γ be the indicator that the treatment
initiation time is less than τ ; i.e., Γ = 1 if the subject initiated the treatment before τ and Γ = 0
otherwise. Let Y (m) be the potential outcome at the end of study τ , had the subject initiated
the treatment at tm, and let Y (∞) be the potential outcome at τ had the subject never initiated
the treatment during the study follow up. Let Vm = (Am−1, Lm) be the vector of treatment and
covariate. Let Y be the continuous outcome measured at τ . Finally, the subject’s full record is
F = (AK , LK , Y ).
Following Lok and DeGruttola (2012), we describe the discrete-time SNMM for the treatment
effect as follows.
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Assumption 1 (Discrete-time SNMM) For 0 ≤ m ≤ K, the discrete-time SNMM is
γm(Lm) = E
{
Y (m) − Y (∞) | Am−1 = 0, Lm
}
= γm(Lm;ψ
∗); (1)
i.e., γm(Lm;ψ) with ψ ∈R
p is a correctly specified model for γm(Lm) with the true parameter value
ψ∗.
This model specifies the conditional expectation of the treatment contrasts Y (m) − Y (∞), given
subject’s observed treatment and covariates history (Am−1 = 0, Lm). Intuitively, it states that the
conditional mean of the outcome is shifted by γm(Lm;ψ∗) had the subject initiated the treatment
at tm comparing to never starting. Therefore, the parameter ψ∗ has a causal interpretation. To
help understand the model, consider γm(Lm;ψ∗) = (ψ∗1 + ψ
∗
2tm)(τ − tm), where ψ
∗ = (ψ∗1 , ψ
∗
2).
This model entails that on average, the treatment would increase the mean of the outcome had the
subject initiated the treatment at tm by (ψ∗1 + ψ
∗
2tm)(τ − tm), and the magnitude of the increase
depends on the duration of the treatment and the treatment initiation time. If ψ∗1 + ψ
∗
2tm > 0 and
ψ∗2 < 0, it indicates the treatment is beneficial and earlier initiation is better.
We make the consistency assumption to link the observed data to the potential outcomes.
Assumption 2 (Consistency) The observed outcome is equal to the potential outcome under the
actual treatment received; i.e., Y = Y (T ).
If all potential outcomes were observed for each subject, we can directly compare these outcomes
to infer the treatment effect; however, the fundamental problem in causal inference is that we can
not observe all potential outcomes for a particular subject (Holland, 1986). In particular, we can
observe Y (∞) only for the subjects who did not initiate the treatment during the follow up. To
overcome this issue, we define
H(ψ∗) = Y − γT (LT ;ψ
∗). (2)
Intuitively, H(ψ∗) subtracts the treatment effect γT (LT ;ψ∗) from the observed outcome Y , so it
mimics the potential outcome Y (∞) had the treatment never been initiated. We provide the formal
statement as proved in Lok and DeGruttola (2012).
Proposition 1 (Mimicking Y (∞)) Under Assumption 2, H(ψ∗) mimics Y (∞), in the sense that
E
{
H(ψ∗) | Am−1 = 0, Am, Lm
}
= E
{
Y (∞) | Am−1 = 0, Am, Lm
}
,
for 0 ≤ m ≤ K, where by convention, E
(
· | A−1 = 0, A0, L0
)
= E
(
· | A0, L0
)
.
We can not fit the SNMM by a regression model pooled over time, because the model in-
volves the unobserved potential outcomes. Parameter identification requires the NUC assumption
(Robins et al., 1992).
Assumption 3 (No unmeasured confounding) Am ⊥ Y
(∞) | (Am−1, Lm) for 0 ≤ m ≤ K,
where ⊥ means “is (conditionally) independent of” (Dawid, 1979).
Assumption 3 holds if (Am−1, Lm) contains all prognostic factors for Y (∞) that affect the treat-
ment decision at tm for 0 ≤ m ≤ K. Under this assumption, the observational study can be
conceptualized as a sequentially randomized experiment.
Proposition 1 implies that under Assumption 3, for 0 ≤ m ≤ K,
E
{
H(ψ∗) | Am−1 = 0, Am, Lm
}
= E
{
H(ψ∗) | Am−1 = 0, Lm
}
; (3)
see, e.g., Robins et al. (1992), Lok et al. (2004), Lok and DeGruttola (2012). Equation (3) also
poses restrictions for ψ∗.
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2.2 Semiparametric efficiency theory
The semiparametric model is characterized by the discrete-time SNMM (1) and restriction (3),
where the parameter of primary interest is ψ∗.
We first present the general semiparametric efficiency theory. Suppose the data consist of n
independent and identically distributed random variables F1, . . . , Fn. We consider regular asymp-
totically linear (RAL) estimators ψ̂n for ψ∗ as
n1/2(ψ̂n − ψ
∗) = n1/2PnΦ(F ) + op(1), (4)
where Pn denotes the empirical mean; i.e., PnΦ(F ) = n−1
∑n
i=1Φ(Fi), Φ(F ) is called the influence
function of ψ̂n, with mean zero and finite and non-singular variance. Because ψ∗ is p-dimensional,
Φ(F ) is also p-dimensional. From (4), the asymptotic variance of n1/2(ψ̂n − ψ∗) is equal to the
variance of its influence function. As a result, to construct the efficient RAL estimator, it suffices
to find the influence function with the smallest variance.
To do this, we take a geometric approach of Bickel et al. (1993). Consider the Hilbert space
H of all p-dimensional, mean-zero finite variance measurable functions of F , denoted by h(F ),
equipped with the covariance inner product < h1, h2 >= E {h1(F )Th2(F )} and the norm ||h|| =
E {h(F )Th(F )}1/2 < ∞. Bickel et al. (1993) stated that influence functions for RAL estimators
lie in the orthogonal complement of the nuisance tangent space in H. To motive the concept
of the nuisance tangent space for a semiparametric model, we first consider a fully parametric
model f(F ;ψ, θ), where ψ is a p-dimensional parameter of interest, and θ is an q-dimensional
nuisance parameter. The score vectors of ψ and θ are Sψ(F ) = ∂ log f(F ;ψ, θ∗)/∂ψ and Sθ(F ) =
∂ log f(F ;ψ∗, θ)/∂θ, both evaluated at the true values (ψ∗, θ∗), respectively. For a parametric model,
the nuisance tangent space Λ is the linear space in H spanned by the q-dimensional nuisance score
vector Sθ(F ). For semiparametric models, where the nuisance parameter is infinite-dimensional,
the nuisance tangent space Λ is defined as the mean squared closure of all parametric sub-model
nuisance tangent spaces. The efficient score Seff(F ) for the semiparametric model is the projection
of Sψ onto the orthogonal complementary space of the nuisance tangent space Λ⊥; i.e., Seff(F ) =∏(
Sψ | Λ
⊥
)
, where
∏
is the projection operator in the Hilbert space. The efficient influence
function is Φeff(F ) = [E {Seff(F )Seff (F )T}]
−1 Seff(F ), with the variance [E {Seff(F )Seff (F )T}]
−1,
which achieves the semiparametric efficiency bound (Bickel et al., 1993). From this geometric point
of view, to derive efficient semiparametric estimators for ψ∗, it suffices to find the efficient score
Seff(F ).
2.3 Influence functions
The key step is to characterize the space where the influence functions of RAL estimators belong
to, i.e., the orthogonal complementary space of the nuisance tangent space Λ⊥. Following Robins
(1994), Proposition 2 characterizes all influence functions of RAL estimators for ψ∗.
Proposition 2 For the semiparametric model characterized by the discrete-time SNMM (1) and
restriction (3), the influence function space for ψ∗ is
Λ⊥ =
{
G(ψ∗;F, c) : for all c(V m) ∈ R
p
}
, (5)
where V m = (Am−1, Lm) and
G(ψ;F, c) =
K∑
m=1
c(V m){Am − P (Am = 1 | V m)}[H(ψ) − E{H(ψ) | V m}],
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indexed by c. To make the notation accurate, the abbreviation c in G(ψ;F, c) means c(V m).
Although Robins (1994) provided this result, the technical proofs were dense and less accessible
to general readers. In the future, we will write a technical report that provides details to guide
general readers in deriving the semiparametric efficiency theory in similar contexts.
The semiparametric efficiency score, i.e. the most efficient one among the class in (5), often does
not have a closed-form expression. We now make a working assumption, which extends restriction
(3) and allows us to derive an analytical expression of the semiparametric efficient score of ψ∗.
Assumption 4 (Homoscedasticity) For 0 ≤ m ≤ K, var{H(ψ∗) | Am, Lm} = var
{
H(ψ∗) | V m
}
.
Proposition 3 (Discrete-time semiparametric efficient score) Consider γm(Lm;ψ
∗) = (ψ∗1+
ψ∗2tm)(τ − tm). Suppose Assumptions 2–4 holds. The semiparametric efficient score of ψ
∗ is
Seff(ψ
∗;F ) = G(ψ∗;F, ceff ), (6)
where
ceff (V m) =
(
(τ − tm)− E
{
dur(tm) | Am = 0, Lm
}
tm(τ − tm)− E
{
T × dur(tm) | Am = 0, Lm
} ) [var{H(ψ∗) | V m}]−1 ,
and dur(tm) =
∑K−1
l=m Al(tl+1 − tl) is the observed treatment duration from tm to τ .
3 SNMMs in continuous-time processes
3.1 Setup, models, and assumptions
We now extend the discrete-time SNMM in Section 2 to the continuous-time SNMM. We assume
that the variables can change their values at any real time between 0 and τ . We assume that all
subjects are followed until τ and consider censoring in Section 3.4. Let Lt be the multidimensional
covariate process. Let At be the binary treatment process. Define Y (t) as the potential outcome
at τ had the subject initiated the treatment at t, and define Y (∞) as the potential outcome at τ
had the subject never initiated the treatment before τ . Let Y be the continuous outcome measured
at τ . For the regularization purpose, we assume that the processes are Càdlàg processes, i.e., the
processes are right continuous with left limits. Let Vt = (At−, Lt) be the combined covariate and
treatment process, where At− is the available treatment information right before t. We use the
overline notation to denote a variable’s history; e.g., At = {Au : 0 ≤ u ≤ t}. Finally, the subject’s
full record is F = {V τ , (Y (t) : 0 ≤ t ≤ τ)}.
We assume the continuous-time SNMM as follows.
Assumption 5 (Continuous-time SNMM) For 0 ≤ t ≤ τ , the continuous-time SNMM is
γt(Lt) = E
{
Y (t) − Y (∞) | Lt, T ≥ t
}
= γt(Lt;ψ
∗); (7)
i.e., γt(Lt;ψ) with ψ ∈R
p is a correctly specified model for γt(Lt) with the true parameter value ψ
∗.
Moreover, Y (t) ∼ Y (∞)+ γt(Lt;ψ
∗) given (Lt, T ≥ t), where ∼ means “is (conditionally) distributed
as”.
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In the continuous-time SNMM (7), ψ∗ can be interpreted as the treatment effect rate for the
outcome. We also assume that given (Lt, T ≥ t), the treatment effect only changes the location of the
distribution of the outcome but not on other aspects of the distribution such as the variance. This
assumption is weaker than the rank-preserving assumption of Y (t) = Y (∞) + γt(Lt;ψ∗) considered
in Zhang et al. (2011). It has been argued that by mapping the potential outcomes directly rather
than between distributions, rank preserving models are easier to understand and communicate
(Vansteelandt et al., 2014). However, the rank preservation may be restrictive in practice, because
it implies that for two subjects i and j with the same treatment and covariate history, Yi > Yj must
imply Y (∞)i > Y
(∞)
j . We relax this restriction by imposing a distributional assumption.
The continuous-time SNMM (7) can model the treatment effect flexibly. For example, the two-
parameter model γt(Lt;ψ) = (ψ1 + ψ2t)(τ − t)I(t ≤ τ) entails that the treatment effect depends
on the treatment initiation time and the duration of the treatment. To allow for treatment effect
modifiers, we can specify an elaborated treatment effect model including time-varying covariates.
We discuss effect modification and model selection in Section 7.
To link the observed outcome to the potential outcomes, we assume that Y = Y (T ). Define the
mimicking outcome for Y (∞) as H(ψ∗) = Y − γT (LT ;ψ∗). By Assumption 5, H(ψ∗) ∼ Y (∞), given
(Lt, T ≥ t).
An important issue with data from user-initiated visits and treatment initiation is the poten-
tial selection bias and confounding, e.g., sicker patients may visit the doctor more frequently and
are more likely to initiate treatment. To overcome this issue, we impose the NUC assumption
(Yang et al., 2018).
Assumption 6 (No unmeasured confounding) The hazard of treatment initiation is
λT (t | F ) = lim
h→0
h−1P (t ≤ T < t+ h,Γ = 1 | F, T ≥ t)
= lim
h→0
h−1P (t ≤ T < t+ h,Γ = 1 | V t, T ≥ t) = λT
(
t | V t
)
. (8)
Assumption 6 implies that the hazard of observed treatment initiation at t depends only on the
past treatment and covariate history V t but not on the future observations and potential outcomes.
This assumption holds if the set of historical covariates contains all prognostic factors for the
outcome that affect the decision of patient visiting the doctor and initiating treatment.
The treatment process At can also be represented in terms of the counting process NT (t) and
the at-risk process YT (t) of observing treatment initiation. Let σ(Vt) be the σ-field generated by
Vt, and let σ(V t) be the σ-field generated by ∪u≤tσ(Vu). Under the standard regularity conditions
for the counting process, MT (t) = NT (t) −
∫ t
0 λT (u | V u)YT (u)du is a martingale with respect to
the filtration σ(V t). Assumption 6 entails that the jumping rate of NT (t) at t does not depend on
Y (∞), given V t. Because H(ψ∗) mimics Y (∞) in the sense that it has the same distribution as Y (∞)
given V t, Assumption 6 also implies that the jumping rate of NT (t) at t does not depend on H(ψ∗),
given V t. To be formal, we show in the supplementary material that
λT {t | V t,H(ψ
∗)} = λT (t | V t). (9)
Therefore, under the standard regularity conditions, MT (t) is a martingale with respect to the filtra-
tion σ{V t,H(ψ∗)}. Lok (2008) imposed this martingale condition to formulate the NUC assumption
for the treatment process.
3.2 Semiparametric efficiency score
We establish the new semiparametric efficiency theory for the continuous-time SNMMs. We defer
major proofs to Section 8.
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Theorem 1 For the semiparametric model characterized by the continuous-time SNMM (7) and
Assumption 6, the influence function space for ψ∗ is
Λ⊥ =
{
G(ψ∗;F, c) : for all c(V u) ∈ R
p
}
,
where
G(ψ;F, c) =
∫ τ
0
c(V u)
[
H(ψ)− E
{
H(ψ) | V u, T ≥ u
}]
YT (u)dMT (u). (10)
The semiparametric efficiency score for ψ∗ is Seff(ψ∗;F ) =
∏
{S(ψ∗;F ) | Λ⊥}. To derive
Seff(ψ
∗;F ), we calculate the projection of any B = B(F ) onto Λ⊥.
Theorem 2 For any B = B(F ), the projection of B onto Λ⊥ is∏(
B | Λ⊥
)
=
∫ τ
0
[
E
{
BH˙u(ψ
∗) | V u, T = u
}
− E
{
BH˙u(ψ
∗) | V u, T ≥ u
}]
×
[
var
{
H(ψ∗) | V u, T ≥ u
}]−1 [
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u
}]
dMT (u), (11)
where H˙u(ψ
∗) = H(ψ∗)− E{H(ψ∗) | V u, T ≥ u}.
Considering B = S(ψ∗;F ) in Theorem 2, we can derive the semiparametric efficient score for
ψ∗.
Theorem 3 (Continuous-time semiparametric efficient score) For the semiparametric model
characterized by the continuous-time SNMM (7) and Assumption 6, the semiparametric efficient
score of ψ∗ is
Seff(ψ
∗;F ) = G(ψ∗;F, ceff ), (12)
where G(ψ;F, c) is defined in (10), and
ceff(V u) = [E{∂H˙u(ψ
∗)/∂ψ | V u, T = u}
− E{∂H˙u(ψ
∗)/∂ψ | V u, T ≥ u}]× [var{H(ψ
∗) | V u, T ≥ u}]
−1. (13)
To illustrate the theorem, we provide the explicit expression of the semiparametric efficient score
using an example.
Example 1 Consider γt(Lt;ψ) = (ψ1 + ψ2t)(τ − t)I(t ≤ τ). Suppose Assumption 6 holds. The
semiparametric efficient score of ψ∗ is Seff(ψ
∗;F ) = G(ψ∗;F, ceff ), where
ceff(V u) =
(
(τ − u)I(u ≤ τ)− E{(τ − T )I(T ≤ τ) | V u, T ≥ u}
u(τ − u)I(u ≤ τ)− E{T (τ − T )I(T ≤ τ) | V u, T ≥ u}
)
× [var{H(ψ∗) | V u, T ≥ u}]
−1. (14)
Remark 1 The proposed continuous-time semiparametric efficient score contains the discrete-time
semiparametric efficient score as a special case. If the processes take observations at discrete times
{t0, . . . , tK}, then (i) the conditioning event (V u, T ≥ u) at tm is the same as (Am = 0, Lm), (ii)
MT (t) = NT (t)−
∫ t
0 λT (u | V u)YT (u)du at t = tm becomes Am − P (Am = 1 | Am−1 = 0, Lm), and
E{∂H˙t(ψ
∗)/∂ψ | V t, T = t} at t = tm becomes
E{∂H˙m(ψ
∗)/∂ψ | V m, T = tm} = −
(
(τ − tm)− E
{
dur(tm) | Am = 0, Lm
}
tm(τ − tm)− E
{
T × dur(tm) | Am = 0, Lm
} ) .
Therefore, the continuous-time semiparametric efficient score (12) reduces to the discrete-time semi-
parametric efficient score (6).
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3.3 Doubly robust and locally efficient estimators
We now construct a general class of estimators based on the estimating function G(ψ∗;F, c). Because
E{G(ψ∗;F, c)} = 0, we obtain the estimator of ψ∗ by solving
Pn {G(ψ;F, c)} = 0. (15)
In particular, the estimating equation (15) with ceff provides the semiparametric efficient estimator
of ψ∗.
In (15), we assume that the model for the treatment process and E
{
H(ψ∗) | V u, T ≥ u
}
are
known. In practice, they are often unknown and must be modeled and estimated from the data.
We posit a proportional hazards model with time-dependent covariates for the treatment process;
i.e.,
λT
(
t | V t;α
)
= λT,0(t) exp
{
αTWT (t, V t)
}
, (16)
where λT,0(t) is an unknown baseline hazard function, WT (t, V t) is a pre-specified function of t and
V t, and α is a vector of unknown parameters. Under Assumption 6, we can estimate λT,0(t) and α
from the standard software such as “coxph” in R (R Development Core Team, 2012) . To estimate α,
fit the time-dependent proportional hazards model to the data {(V Ti,i, Ti,Γi) : i = 1, . . . , n} treating
the treatment initiation as the failure event. Once we obtain α̂, we can estimate the cumulative
baseline hazard, λT,0(t)dt by
λ̂T,0(t)dt =
∑n
i=1 dNT,i(t)∑n
i=1 exp
{
α̂TWT (t, V t,i)
}
YTi(t)
.
Then, we obtain λ̂T (u | V u) = exp
{
α̂TWT (u, V u)
}
λ̂T,0(u) and M̂T (t) = NT (t) −
∫ t
0 λ̂T (u |
V u)YT (u)du.
We also posit a working model E
{
H(ψ∗) | V u, T ≥ u;β
}
, such as a linear regression model,
where β is a vector of unknown parameters.
The estimating equation for ψ∗ achieves the double robustness or double protection (Rotnitzky and Vansteelandt,
2015).
Theorem 4 (Double robustness) Under the continuous-time SNMM (7) and Assumption 6, the
proposed estimator ψ̂ solving the estimating equation (15) is doubly robust in that it is unbiased if
either the model for the treatment process is correctly specified, or the potential outcome mean model
E
{
H(ψ∗) | V u, T ≥ u;β
}
is correctly specified, but not necessarily both.
The choice of c does not affect the double robustness but the efficiency of the resulting estimator.
For efficiency consideration, we consider ceff in (13). The resulting estimator solving the estimating
equation (15) with ceff is locally efficient, in the sense that it achieves the semiparametric efficiency
bound if the working models for the treatment process and the potential outcome mean are correctly
specified. Because ceff depends on the unknown distribution, we require additional models for
E{(τ − T )I(T ≤ τ) | V u, T ≥ u} and E{T (τ − T )I(T ≤ τ) | V u, T ≥ u} to approximate ceff . For
example, we can approximate E{(τ −T )I(T ≤ τ) | V u, T ≥ u} by P (T ≤ τ | V u, T ≥ u)×E{τ −T |
V u, u ≤ T ≤ τ} and each approximated by (logistic) linear models. For var{H(ψ∗) | V u, T ≥ u},
we consider the following options: (i) assume var{H(ψ∗) | V u, T ≥ u} to be a constant, and (ii)
approximate var{H(ψ∗) | V u, T ≥ u} by the sample variance of H(ψ̂p) among subjects with T ≥ u,
where ψ̂p is a preliminary estimator. We compare the two options via simulation. Although option
(ii) provides a slight efficiency gain in estimation, for ease of implementation we recommend option
(i). Option (i) is common in the generalized estimating equation framework. From here on, we use
this option for c and suppress the dependence on c for estimating functions.
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3.4 Censoring
In most longitudinal observational studies, subjects may drop out the study prematurely before the
end of study, which renders the data censored at the time of dropout. If the censoring mechanism
depends on time-varying prognostic factors, e.g. sicker patients drop out of the study with a higher
probability than healthier patients, the patients remaining in the study is a biased sample of the
full population. We now introduce C to be the time to censoring. Let X = min(C, τ) be time to
censoring or the end of the study, whichever came first. Let δC = I(C ≥ τ) be the indicator of not
censoring before τ . The observed data is O = (X,V X , δC , δCY ).
In the presence of censoring, the estimating equation (15) is not feasible. We consider inverse
probability of censoring weighting (IPCW; Robins, 1993). We assume a dependent censoring mech-
anism as follows.
Assumption 7 (Dependent censoring) The hazard of censoring is
λC(t | F, T > t) = lim
h→0
h−1P (t ≤ C < t+ h | F, T > t,C ≥ t)
= lim
h→0
h−1P (t ≤ C < t+ h | V t, T > t,C ≥ t) = λC
(
t | V t
)
. (17)
Assumption 7 states that λC(t | F, T > t) depends only on the past treatment and covariate
history until t, but not on the future variables and potential outcomes. This assumption holds if the
set of historical covariates contains all prognostic factors for the outcome that affect the possibility
of loss to follow up at t. Under this assumption, the missing data due to censoring are missing at
random (Rubin, 1976).
We discuss the implication of Assumption 7 on estimation of the treatment process model. Under
Assumption 7, the hazard of treatment initiation in (8) is equal to limh→0 h−1P (t ≤ T < t+h,Γ =
1 | V t, T > t,C ≥ t). Redefining T to be the time to treatment initiation, or censoring, or the end
of the study, whichever came first, (8) can be estimated by conditioning on T ≥ t with the new
definition of T.
From λC
(
t | V t
)
, we define KC
(
t | V t
)
= exp
{
−
∫ t
0 λC
(
u | V u
)
du
}
, which is the probability
of the subject not being censored before t. For regularity, we impose a positivity condition for
KC
(
t | V t
)
.
Assumption 8 (Positivity) There exists a constant δ such that with probability one, KC
(
t | V t
)
≥
δ > 0 for t in the support of T .
Following Rotnitzky et al. (2007), we obtain the IPCW estimator ψ̂ as the solution to the fol-
lowing equation:
Pn
{
δC
KC(τ | V τ )
G(ψ;F )
}
= 0. (18)
In (18), we assume that KC(t | V t) is known. In practice, KC(t | V t) is often unknown and
must be modeled and estimated from the data. To facilitate estimation, we posit a proportional
hazards model for the censoring process with time-dependent covariates; i.e.,
λC(t | V t) = λC,0(t) exp{η
TWC(t, V t)}, (19)
where λC,0(t) is an unknown baseline hazard function for censoring, WC(t, V t) is a pre-specified
function of t and V t, and η is a vector of unknown parameters. Under Assumption 7, we can
estimate λC,0(t) and α from the standard software such as “coxph” in R. To estimate η, fit the
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time-dependent proportional hazards model to the data {(V Xi,i,Xi, δC,i) : i = 1, . . . , n} treating
the censoring as the failure event. Once we obtain η̂, we can estimate λC,0(t)dt by
λ̂C,0(t)dt =
∑n
i=1 dNC,i(t)∑n
i=1 exp
{
η̂TWC(t, V t,i)
}
YCi(t)
,
where NC(t) = I(C ≤ t, δC = 0) and YC(t) = I(C ≥ t) are the counting process and the at-risk
process of observing censoring. Then, we estimate KC
(
t | V t
)
by
K̂C
(
t | V t
)
= exp
[
−
∫ t
0
exp{η̂TWC(u, V u)}λ̂C,0(u)du
]
=
∏
0≤u≤t
[
1− exp
{
η̂TWC(u, V u)
}
λ̂C,0 (u) du
]
.
Then, we obtain the estimator ψ̂ of ψ by solving (18) with unknown quantities replaced by their
estimates.
In the literature, augmented IPCW estimators have been developed to improve efficiency and
robustness over IPCW estimators; see, e.g., Rotnitzky et al. (2007, 2009) for survival data and
Lok et al. (2017) for competing risks data. However, the typical efficiency gain is little in practice
at the expense of additional complexity in computation. More importantly, we show in the next
section that the proposed IPCW estimator already has the multiple robustness property against
possible model misspecification.
4 Multiple robustness and asymptotic distribution
Because the proposed estimator depends on nuisance parameter estimation, we summarize the
following nuisance models: (i) E{H(ψ∗) | V u, T ≥ u;β} indexed by β; (ii) the proportional hazards
model for the treatment process (16), denoted by MT ; and (iii) the proportional hazards model
for the censoring process (19), denoted by KC . Let β̂, M̂T , and K̂C be the estimates of β, MT ,
and KC under the specified parametric and semiparametric models. Denote the probability limits
of β̂, M̂T , and K̂C as β∗, M∗T , and K
∗
C , respectively. If the outcome model is correctly specified,
E{H(ψ∗) | V u, T ≥ u;β
∗} = E{H(ψ∗) | V u, T ≥ u}; if the model for the treatment process is
correctly specified, M∗T = MT ; and if the model for the censoring process is correctly specified,
K∗C = KC . To reflect that the estimating function depends on the nuisance parameters, we denote
G(ψ, β,MT ;F ) =
∫
c(V u)
[
H(ψ) − E
{
H(ψ) | V u, T ≥ u;β
}]
dMT (u),
Φ(ψ, β,MT ,KC ;F ) =
δCG(ψ, β, λT ;F )
KC
(
τ | V τ
) .
Then, the proposed estimator ψ̂ solves
Pn
{
Φ(ψ, β̂, M̂T , K̂C ;F )
}
= 0, (20)
for ψ, which achieves the multiple robustness or multiple protection (Molina et al., 2017).
Theorem 5 (Multiple robustness) Under the continuous-time SNMM (7) and Assumption 6,
the proposed estimator ψ̂ solving estimating equation (20) is multiply robust in that it is unbiased
under all scenarios specified in Table 1.
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Table 1: Multiply Robustness of the Proposed Estimator
Scenario (a) (b) (c) (d) (e) (f)
Model for H(ψ∗)   ×   ×
Model for the treatment process MT  ×   × 
Model for the censoring process KC    × × ×
 (is correctly specified), × (is misspecified)
It is important to establish the asymptotic property of ψ̂ under the multiple robustness condition,
which allows for multiply robust inference of ψ∗. Let P denote the true data generating distribution
of F , and for any g(F ), let P{g(F )} =
∫
g(f)dP (f) and let Gn = n1/2(Pn − P). We define
J1(β) = P {Φ(ψ
∗, β,M∗T ,K
∗
C ;F )} ,
J2(MT ) = P {Φ(ψ
∗, β∗,MT ,K
∗
C ;F )} ,
J3(KC) = P {Φ(ψ
∗, β∗,M∗T ,KC ;F )} ,
and
J(β,MT ,KC) = P {Φ(ψ
∗, β,MT ,KC ;F )} .
Similar to Yang and Lok (2016), we impose the regularity conditions from the empirical process
literature (van der Vaart and Wellner, 1996).
Assumption 9 (i) Φ(ψ, β,MT ,KC ;F ) and ∂Φ(ψ, β,MT ,KC ;F )/∂ψ are P -Donsker classes; i.e.,
Gn{Φ(ψ̂, β̂, M̂T , K̂C ;F )} = Gn{Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F )}+ op(1),
Gn
{
∂Φ(ψ̂, β̂, M̂T , K̂C ;F )
∂ψ
}
= Gn
{
∂Φ(ψ∗, β∗,M∗T ,K
∗
C ;F )
∂ψ
}
+ op(1).
(ii) Assume that
P
{
||Φ(ψ∗, β̂, M̂T , K̂C ;F )− Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F )||
}
= op(1),
P
{
||
∂
∂ψ
Φ(ψ̂, β̂, M̂T , K̂C ;F )−
∂
∂ψ
Φ(ψ∗, β∗,M∗T ,K
∗
C ;F )||
}
= op(1).
(iii) A(ψ∗, β∗,M∗T ,K
∗
C) = P {∂Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F )/∂ψ} is invertible.
(iv) Assume that
J(β̂, M̂T , K̂C)− J(β
∗,M∗T ,K
∗
C) = J1(β̂)− J1(β
∗) + J2(M̂T )− J2(M
∗
T )
+ J3(K̂C)− J3(K
∗
C) + op(n
−1/2),
and that J1(β̂), J2(M̂T ), and J3(K̂C) are regular asymptotically linear with influence functions
Φ1(ψ
∗, β∗,M∗T ,K
∗
C ;F ), Φ2(ψ
∗, β∗,M∗T ,K
∗
C ;F ), and Φ3(ψ
∗, β∗,M∗T ,K
∗
C ;F ), respectively.
We discuss the implications of these conditions. First, the P -Donsker class condition requires
that the nuisance models should not be too complex. Under Assumption 8 for the censoring process,
Assumption 9 (i) is a standard condition for the empirical processes. We refer the interested readers
to Section 4.2 of Kennedy (2016) for a thorough discussion of Donsker classes of functions. Second,
Assumption 9 (ii) states that β̂, M̂T , and K̂C have probability limits β∗, M∗T , and K
∗
C , and that
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the multiple robustness condition in Theorem 5 holds. Third, Assumption 9 (iv) holds for smooth
functionals of parametric or semiparametric efficient estimators under specified models. Therefore,
this assumption would hold under mild regularity conditions if β̂, M̂T , and K̂C are the parametric
and semiparametric maximum likelihood estimators under specified models.
We present the asymptotic property of the proposed estimator ψ̂ solving equation (20).
Theorem 6 Under the continuous-time SNMM (7) and Assumptions 6, 8 and 9, ψ̂ is consistent
for ψ∗ and is asymptotically linear with the influence function
Φ˜(ψ∗, β∗,M∗T ,K
∗
C ;F ) = {A(ψ
∗, β∗,M∗T ,K
∗
C)}
−1 B˜(ψ∗, β∗,M∗T ,K
∗
C ;F ),
where A(ψ∗, β∗,M∗T ,K
∗
C) is defined in Assumption 9 (iii), and
B˜(ψ∗, β∗,M∗T ,K
∗
C ;F ) = Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + Φ1(ψ
∗, β∗,M∗T ,K
∗
C ;F )
+Φ2(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + Φ3(ψ
∗, β∗,M∗T ,K
∗
C ;F ). (21)
Theorem 6 allows for variance estimation of ψ̂. If the nuisance models are correctly specified,
we have
B˜(ψ∗, β∗,MT ,KC ;F ) = Φ(ψ
∗, β∗,MT ,KC ;F )− E {Φ(ψ
∗, β∗,MT ,KC ;F )S
T
α}E (SαS
T
α)
−1
Sα
−E
{
Φ(ψ∗, β∗,MT ,KC ;F )S
T
η
}
E
(
SηS
T
η
)−1
Sη
+
∫
E
[
G(ψ∗, β∗,MT ;F ) exp
{
αTWT (u, V u)
}
δC/KC(τ | V τ )
]
E
[
exp
{
αTWT (u, V u)
}
YT (u)
] dMC(u)
+
∫
E
[
G(ψ∗, β∗,MT ;F ) exp
{
ηTWC(u, V u)
}
δC/KC(τ | V τ )
]
E
[
exp
{
ηTWC(u, V u)
}
YC(u)
] dMT (u),22)
where Sα and Sη are the scores of the partial likelihood functions of α and η, respectively; see (S12)
and (S13) in the supplementary material.
Then, we obtain the variance estimator of ψ̂ as the empirical variance of the individual influence
function with the unknown parameters replaced by their estimates. Under the multiple robustness
condition if some nuisance models are misspecified, it is difficult to characterize the influence func-
tion Φ˜(ψ∗, β∗,M∗T ,K
∗
C ;F ). We suggest estimating the asymptotic variance of ψ̂ by nonparametric
bootstrap (Efron, 1979). The consistency of the bootstrap is guaranteed by the regularity and
asymptotic properties of ψ̂ in Theorem 6.
5 Simulation study
We now evaluate the finite-sample performance of the proposed estimator on simulated datasets
with two objectives. First, we assess the double robustness and efficiency of the proposed estimator
based on the semiparametric efficiency score, compared to some preliminary estimator. Second, to
demonstrate the impact of data gridization as commonly done in practice, we include the g-estimator
applied to the pre-processed data.
We simulate 1, 000 datasets under two settings with and without censoring. In Setting I, we
generate two covariates, one time-independent (LTI) and one time-dependent (LTD). The time-
independent covariate is generated from a Bernoulli distribution with mean equal to 0.55. The time-
dependent covariate is a 1 × 4 row vector generated from a multivariate normal distribution with
mean equal to (0, 0, 0, 0) and covariance equal to 0.7|i−j| fori, j = 1, . . . , 4. This vector represents
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Table 2: Simulation results in Setting I without censoring based on 1, 000 simulated datasets: the
Monte Carlo bias, standard error, root mean square error of the estimators, and coverage rate of
95% confidence intervals.
Bias (×102) SE (×102) rMSE (×102) CR (×102)
n Method ψ∗1 ψ
∗
2 ψ
∗
1 ψ
∗
2 ψ
∗
1 ψ
∗
2 ψ
∗
1 ψ
∗
2
Scenario (i) with MT ()
Model for H(ψ∗) (×) ψ̂p 0.3 -0.1 5.3 9.6 5.3 9.6 95.0 94.0
1000 Model for H(ψ∗) ()
ψ̂cont,1 0.2 0.1 5.0 8.9 5.0 8.9 95.4 94.0
ψ̂cont,2 0.2 0.1 4.9 8.7 4.9 8.7 95.3 94.4
– ψ̂disc,g 28.6 34.5 6.0 10.5 29.3 36.1 0.0 7.2
Model for H(ψ∗) (×) ψ̂p 0.2 -0.1 3.4 6.2 3.4 6.2 95.9 96.0
2000
Model for H(ψ∗) ()
ψ̂cont,1 0.1 0.1 3.3 5.8 3.3 5.8 95.2 95.4
ψ̂cont,2 0.1 0.1 3.2 5.6 3.2 5.6 95.1 95.6
– ψ̂disc,g 27.8 37.1 3.9 6.7 28.1 37.7 0.0 0.0
Scenario (ii) with MT (×)
Model for H(ψ∗) (×) ψ̂p 7.4 20.2 5.2 9.9 9.1 22.5 68.8 44.6
1000 Model for H(ψ∗) ()
ψ̂cont,1 0.5 0.5 5.1 9.1 5.1 9.1 95.4 94.0
ψ̂cont,2 0.5 0.4 5.1 9.0 5.1 9.0 95.0 95.4
– ψ̂disc,g 27.7 38.6 5.9 10.2 28.4 40.0 0.2 3.4
Model for H(ψ∗) (×) ψ̂p 7.4 20.1 3.5 6.4 8.1 21.1 46.2 17.2
2000
Model for H(ψ∗) ()
ψ̂cont,1 0.4 0.3 3.4 5.9 3.4 5.9 95.0 95.4
ψ̂cont,2 0.3 0.3 3.4 5.8 3.4 5.8 95.3 95.6
– ψ̂disc,g 27.3 39.5 3.9 6.7 27.6 40.0 0.0 0.0

(is correctly specified), × (is misspecified)
the value of LTD,t at t1 = 0, t2 = 0.5, t3 = 1, and t4 = 1.5 (in year). We assume that the time-
dependent variable remains constant between measurements. The maximum follow up time is τ = 2.
We generate the time to treatment initiation T with the hazard rate λT (t | V t) = λT,0(t) exp(α1
×LTI + α2LTD,t) with λT,0(t) = λT,0 = 0.4, α1 = 0.15, and α2 = 0.8. We generate T according
to the time-dependent model sequentially. This is because the hazard of treatment initiation in
the time interval from t1 = 0 to t2 = 0.5 differs from the hazard of treatment initiation in the
next interval and so on; see the supplementary material for details. We let Y (∞) = LTD,τ be the
potential outcome had the subject never initiated the treatment before τ . The observed outcome is
Y = Y (∞)+ γT (V T ;ψ
∗), where γt(V t;ψ∗) = (ψ∗1 +ψ
∗
2t)(τ − t)I(t ≤ τ) with ψ
∗
1 = 15 and ψ
∗
2 = −1.
We consider the following estimators with details for the nuisance models and their estimation
presented in the supplementary material:
(a) A preliminary estimator ψ̂p solves the estimating equation (S2) with E{H(ψ∗) | V u, T ≥ u} ≡ 0
and c(V u) = (1, u)T(τ − u)I(u ≤ τ)− E{(1, T )T(τ − T )I(T ≤ τ) | V u, T ≥ u}. Therefore, ψ̂p
corresponds to the proposed estimator with a misspecified model for E{H(ψ∗) | V u, T ≥ u}.
(b) The proposed estimator ψ̂cont,1 solves the estimating equation (S2), where we replace var{H(ψ) |
V u, T ≥ u} by a constant.
(c) The proposed estimator ψ̂cont,2 solves the estimating equation (S2), where we obtain v̂ar{H(ψ∗) |
V u, T ≥ u} by the empirical variance of H(ψ̂p)− E{H(ψ̂p) | V u, T ≥ u; β̂}, restricted to sub-
jects with T ≥ u.
(d) The g-estimator ψ̂disc,g in Section 2 applies to the monthly data after gridization with 24
15
equally-spaced time points from 0 to τ . For m ≥ 1, at the mth time point tm, Lm is the
the average of Lt from tm−1 ≤ t ≤ tm, Am is the indicator of whether the treatment is
initiated before tm, and the time to treatment initiation T is tm if Am = 1 and Am−1 = 0.
The g-estimator solves the estimating equation based on (6), where the nuisance models are
estimated similar to what are used for ψ̂cont,1 but with the re-shaped data.
To investigate the double robustness in Theorem 4, we consider two models for estimating MT :
the correctly specified proportional hazards model with both time-independent and time-dependent
covariates; and the misspecified proportional hazards model with only time-independent covariate.
For all estimators, we use the bootstrap for variance estimation with the bootstrap size 100.
Table 2 shows the simulation results in Setting I. Under Scenario (i) when the model for the
treatment process is correctly specified, ψ̂p, ψ̂cont,1 and ψ̂cont,2 show small biases. As a result,
the coverage rates are close to the nominal level. Under Scenario (ii) when the model for the
treatment process is misspecified, ψ̂p shows large biases, but ψ̂cont,1 and ψ̂cont,2 still show small biases.
Moreover, the root mean squared errors of ψ̂cont,1 and ψ̂cont,2 decrease as the sample size increases.
This confirms the double robustness of the proposed estimators. The proposed estimator ψ̂cont,2
with v̂ar{H(ψ∗) | V u, T ≥ u} produces slightly smaller standard errors; however, this reduction is
not large. In practice, we recommend ψ̂cont,1 because of its simpler implementation than ψ̂cont,2.
We note large biases in the g-estimator, which illustrates the consequence of data pre-processing for
the subsequent analysis.
In Setting II, we further generate the time to censoring C with the hazard rate λC(t | V t) =
λC,0(t) exp(η1LTI+η2LTD,t), with λC,0(t) = 0.2, and η1 = η2 = 0.2. In the presence of censoring, we
consider the four estimators (a)–(d) considered in Setting I with weighting; i.e., the corresponding
estimating functions are now weighted by δC/K̂C(τ | V τ ). To investigate the multiple robustness
in Theorem 5, we additionally consider two models for estimating KC : the correctly specified
proportional hazards model with both time-independent and time-dependent covariates; and the
misspecified proportional hazards model without covariate.
Table 3 shows the simulation results in Setting II. Under Scenarios (i) and (iii) when the model
for the treatment process is correctly specified, ψ̂p, ψ̂cont,1 and ψ̂cont,2 show small biases, regardless
whether the models for H(ψ∗) and the censoring process are correctly specified or not. Moreover,
under Scenarios (ii) and (iv) when the model for the treatment process is misspecified, ψ̂p shows
large biases, buy as predicted by the multiple robustness, ψ̂cont,1 and ψ̂cont,2 still show small biases.
Again, the discretized g-estimator shows large biases across all scenarios.
6 Application
We apply our method to the observational Acute Infection and Early Disease Research Program
(AIEDRP) database consisting of 1762 HIV-positive patients diagnosed during acute and early
infection. Lok and DeGruttola (2012) investigated how the time to initiation of highly active an-
tiretroviral treatment (HAART) after HIV infection predicts the effect of one year of treatment
based on this database. Yang and Lok (2016, 2018) developed a goodness-of-fit procedure to assess
the treatment effect model and a sensitivity analysis to the departure of the NUC assumption. Their
analyses showed that HAART is beneficial for HIV-positive patients in acute and early infection,
with a possible increased beneficial effect of earlier HAART initiation. All these methods were
based on the monthly data after gridization. However, the observations from the original data are
collected by user-initiated visits and are irregularly spaced. We aim to estimate the averaged causal
effect of the time to HAART initiation and the mean CD4 counts at year 2 after HIV infection
directly based on the original data.
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Table 3: Simulation results in Setting II with censoring based on 1, 000 simulated datasets: the
Monte Carlo bias, standard error, root mean square error of the estimators, and coverage rate of
95% confidence intervals.
Bias (×102) SE (×102) rMSE (×102) CR (×102)
n Method ψ∗1 ψ
∗
2 ψ
∗
1 ψ
∗
2 ψ
∗
1 ψ
∗
2 ψ
∗
1 ψ
∗
2
Scenario (i) with MT () and KC ()
Model for H(ψ∗) (×) ψ̂p -0.1 0.2 5.8 10.9 5.8 10.9 95.2 94.8
1000 Model for H(ψ∗) ()
ψ̂cont,1 -0.1 0.5 5.7 10.3 5.7 10.3 95.4 95.4
ψ̂cont,2 -0.1 0.5 5.6 10.2 5.6 10.2 94.5 95.5
– ψ̂disc,g 27.7 32.5 6.7 12.0 28.5 34.7 2.4 24.6
Model for H(ψ∗) (×) ψ̂p -0.3 0.3 4.2 7.9 4.2 7.9 94.6 94.8
2000
Model for H(ψ∗) ()
ψ̂cont,1 -0.3 0.4 4.2 7.5 4.2 7.5 95.0 94.8
ψ̂cont,2 -0.3 0.4 4.2 7.4 4.2 7.4 95.1 95.0
– ψ̂disc,g 27.5 32.9 4.7 8.2 27.9 33.9 0.0 1.6
Scenario (ii) with MT (×) and KC ()
Model for H(ψ∗) (×) ψ̂p 7.0 21.0 6.0 11.4 9.2 23.9 82.2 57.8
1000 Model for H(ψ∗) ()
ψ̂cont,1 -0.1 1.1 5.7 10.3 5.7 10.4 95.0 95.2
ψ̂cont,2 -0.1 1.1 5.5 10.1 5.5 10.2 95.2 95.3
– ψ̂disc,g 27.4 33.4 6.7 12.0 28.2 35.5 3.2 22.2
Model for H(ψ∗) (×) ψ̂p 7.0 21.2 4.2 8.2 8.2 22.8 63.6 29.2
2000
Model for H(ψ∗) ()
ψ̂cont,1 -0.3 1.0 4.1 7.5 4.2 7.6 94.4 95.2
ψ̂cont,2 -0.3 1.1 4.0 7.4 4.1 7.5 94.7 95.4
– ψ̂disc,g 27.2 33.7 4.7 8.1 27.6 34.7 0.0 1.2
Scenario (iii) with MT () and KC (×)
Model for H(ψ∗) (×) ψ̂p -0.1 0.2 5.8 11.0 5.8 11.0 95.0 95.0
1000 Model for H(ψ∗) ()
ψ̂cont,1 -0.1 0.4 5.7 10.4 5.7 10.4 95.2 95.6
ψ̂cont,2 -0.1 0.3 5.7 10.4 5.7 10.4 95.0 95.3
– ψ̂disc,g 27.7 32.3 6.7 12.1 28.5 34.5 1.8 26.2
Model for H(ψ∗) (×) ψ̂p -0.3 0.4 4.2 7.9 4.3 7.9 95.0 94.8
2000
Model for H(ψ∗) ()
ψ̂cont,1 -0.3 0.4 4.2 7.5 4.2 7.6 95.2 95.4
ψ̂cont,2 -0.3 0.4 4.1 7.2 4.1 7.2 95.4 95.2
– ψ̂disc,g 27.4 32.6 4.7 8.2 27.8 33.7 0.0 1.8
Scenario (iv) with MT (×) and KC (×)
Model for H(ψ∗) (×) ψ̂p 6.9 20.5 5.9 11.3 9.1 23.5 81.0 58.6
1000 Model for H(ψ∗) ()
ψ̂cont,1 -0.0 1.0 5.7 10.4 5.7 10.4 94.8 95.0
ψ̂cont,2 -0.0 1.0 5.5 10.3 5.5 10.3 95.0 95.2
– ψ̂disc,g 27.5 33.1 6.8 12.1 28.3 35.2 3.0 24.0
Model for H(ψ∗) (×) ψ̂p 6.9 20.8 4.1 8.1 8.1 22.3 63.4 30.2
2000
Model for H(ψ∗) ()
ψ̂cont,1 -0.2 0.9 4.2 7.5 4.2 7.6 94.2 95.4
ψ̂cont,2 -0.2 0.8 4.1 7.4 4.1 7.4 94.6 95.6
– ψ̂disc,g 27.2 33.4 4.7 8.1 27.6 34.4 0.0 1.6
 (is correctly specified), × (is misspecified)
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Table 4: Results of the effect of time to HAART initiation on the CD4 count at year 2
Method Est SE lower .95 upper .95 p-val
ψ∗1 cells/mm
3 per month
Proposed 1: ψ̂cont,1 14.1 1.1 12.0 16.3 0.000
Proposed 2: ψ̂cont,2 14.3 1.1 12.2 16.6 0.000
ψ∗2 cells/mm
3 per month2
Proposed 1: ψ̂cont,1 -1.00 0.23 -1.42 -0.50 0.000
Proposed 2: ψ̂cont,2 -1.01 0.23 -1.43 -0.52 0.000
The outcome variable Y is the CD4 count measured by the end of year 2, with the quantile
range from 443 cells/mm3 to 794 cells/mm3. In this database, 45% of patients dropped out of the
study before year 2, rendering 969 patients with complete observations. Among those patients, 36%
of patients did not initiate the treatment before year 2. The observed time to treatment initiation
ranges from 12 days to 282 days. The covariates include age at infection, gender, race, injection
drug ever/never, and time-varying CD4 count and log viral load.
We assume the true treatment effect model to be γ(V u;ψ) = (ψ1 + ψ2t)(τ − t)I(t ≤ τ). We
consider the proposed estimators ψ̂cont,1 and ψ̂cont,2 specified in Section 5. In the estimation pro-
cedure, we fit the models for time to treatment initiation and time to censoring by proportional
hazards models with both time-independent and time-varying confounders, and we fit the outcome
models by linear regression models, adjusting for a rich set of covariates based on the HIV literature
and clinical knowledge. See the supplementary material for details. We use bootstrap for variance
estimation with the bootstrap size 100 and compute the 95% Wald confidence interval.
Table 4 shows the results for the effect of time to HAART initiation on the CD4 count at year 2.
We note only slight differences in the point estimates between our estimators. Based on our results,
on average, initiation of HAART at the time of infection (t = 0) can increase CD4 counts at year
2 by 14.1cells/mm3 per month× 24 months ≈ 338 cells/mm3; while initiation of HAART 3 months
after the time of infection can increase CD4 counts at year 2 by (14.1 − 1.00× 3)× (24− 3) ≈ 233
cells/mm3.
7 Discussion
In this article, we have developed a new semiparametric efficient estimation framework to evaluate
treatment effects with irregularly-spaced longitudinal observations. There are several directions for
future work.
7.1 Other types of outcome
To accommodate different types of outcome, we consider a general specification of the continuous-
time SNMM as
γt(Lt) = g
[
E
{
Y (t) | Lt, T ≥ t
}]
− g
[
E
{
Y (∞) | Lt, T ≥ t
}]
= γt(Lt;ψ
∗), (23)
where g(·) is a pre-specified link function. For the continuous outcome, g(·) can be an identity link,
i.e. g(x) = x, as we adopt in this article. For the binary outcome, g(·) can be a logit link, i.e. g(x) =
logit(x) := log{x/(1 − x)}. Then, (23) specifies the treatment effect on the odds ratio scale, i.e.
odds
{
Y (t) | Lt, T ≥ t
}
/odds
{
Y (∞) | Lt, T ≥ t
}
, where odds(Y | X) = P (Y = 1 | X)/P (Y = 0 |
X). In this case, H(ψ∗) can be constructed as H(ψ∗) = expit
[
logit{E(Y | Lt, T ≥ t)} − γt(Lt;ψ∗)
]
.
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We can develop the corresponding semiparametric efficiency theory for ψ∗ similarly. For a time to
event outcome, we can consider the structural nested failure time models (Robins and Tsiatis, 1991,
Robins, 1992, Yang et al., 2019).
7.2 Effect modification and model selection
Effect modification occurs when the magnitude of the treatment effect varies as a function of
observed covariates. To allow for time-varying treatment effect modifiers, assume γt(V t;ψ∗) =
{ψ∗1 + ψ
∗
2t + ψ
∗T
3 W (t, V t)}(τ − t)I(t ≤ τ), when W (t, V t) is a pre-specified and possibly high-
dimensional function of t and V t. It is important to identify the true treatment effect modifiers,
which can facilitate development of optimal treatment strategies in personalized medicine (Murphy,
2003). We will develop a variable selection procedure for identifying effect modifiers. The insight is
that we have a larger number of estimating functions than the number of parameters. The problem
for effect modifiers selection falls into the recent work of Chang et al. (2018) on high-dimensional
statistical inferences with over-identification.
7.3 Sensitivity analysis to the NUC assumption
The key assumption to identify the causal parameters in the SNMM is the NUC assumption. How-
ever, this assumption is not verifiable based on the observed data. Therefore, it is important to
assess the impact of possible uncontrolled confounding. Yang and Lok (2018) assumed a bias func-
tion b(Lm) = E{Y (∞) | Am−1 = 0, Am = 1, Lm}−E{Y (∞) | Am−1 = 0, Am = 0, Lm} that quantifies
the impact of unmeasured confounding and developed a modified g-estimator for the discrete-time
SNMM. In the future work, we will develop sensitivity analysis for the continuous-time SNMM
to unmeasured confounding based on the bias function b(V t) = E{Y (∞) | V t, T = t} − E{Y (∞) |
V t, T > t}.
8 Proofs
8.1 Proof of Theorem 1
First, we characterize the semiparametric likelihood function of ψ∗ based on a single variable O =
(V τ , Y ). The semiparametric likelihood is
fO
(
V τ , Y
)
=
{
dH(ψ∗)
dY
}
f{V τ ,H(ψ∗)}{V τ ,H(ψ
∗)} = f{V τ ,H(ψ∗)}{V τ ,H(ψ
∗)}, (24)
where the first equality follows by the transformation of O to {V τ ,H(ψ∗)}, and the second equality
follows because dH(ψ∗)/dY = 1. To express (24) further, we let the observed times to treatment
initiation among the n subjects be v0 = 0 < v1 < · · · < vM . By Assumption 6 and (9), we express
fO
(
V τ , Y ;ψ
∗, θ
)
= f {H(ψ∗); θ1}
M∏
k=1
f
{
Lvk | Avk−1 = 0, Lvk−1 ,H(ψ
∗); θ2
}
×
vM∏
v=v1
f
{
Avk | Avk−1 = 0, Lvk ,H(ψ
∗); θ3
}
,
= f {H(ψ∗); θ1}
M∏
k=1
f
{
Lvk | Avk−1 = 0, Lvk−1 ,H(ψ
∗); θ2
}
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×vM∏
v=v1
f
{
Avk | Avk−1 = 0, Lvk ; θ3
}
= f {H(ψ∗); θ1}
M∏
k=1
f
{
Lvk | Avk−1 = 0, Lvk−1 ,H(ψ
∗); θ2
}
×f(T,Γ | V T ; θ3), (25)
where θ = (θ1, θ2, θ3) is a vector of the infinite-dimensional nuisance parameters given the non-
parametric models, and the third equality follows because
∏M
k=1 f
(
Avk | Avk−1 = 0, Lvk ; θ3
)
can be
equivalently expressed as the likelihood based on the data (T,Γ) given V T .
Second, we characterize Λk, the nuisance tangent space for θk, for k = 1, 2, 3. Assuming
f {H(ψ∗); θ1} and
∏M
k=1 f
{
Lvk | Avk−1 = 0, Lvk−1 ,H(ψ
∗); θ2
}
are nonparametric, it follows from
Section 4.4 of Tsiatis (2006) that the tangent space regarding θ1 is
Λ1 = {s {H(ψ
∗)} ∈ Rp : E [s {H(ψ∗)}] = 0} ,
and the tangent space of θ2 is
Λ2 =
M∑
k=1
{
S
{
V vk−1, Lvk ,H(ψ
∗)
}
∈ Rp :
E
[
S
{
V vk−1, Lvk ,H(ψ
∗)
}
| Avk−1 = 0, Lvk−1 ,H(ψ
∗)
]
= 0
}
.
By writing
f(T,Γ|V T )(T,Γ | V T ) = λT (T | V T )
Γ exp
{
−
∫ T
0
λT (u | V u)du
}
×
{
fT |V T (T | V T )
}1−Γ{∫ ∞
T
fT |V T (u | V u)du
}Γ
,
it follows from Tsiatis (2006) that the tangent space of θ3 is
Λ3 =
{∫
hu(V u)dMT (u) : for all hu(V u) ∈ R
p
}
.
Then, the nuisance tangent space becomes Λ = Λ1 ⊕ Λ2 ⊕ Λ3, where ⊕ denotes a direct sum. This
is because θ1, θ2, and θ3 separate out in the likelihood function and therefore Λ1, Λ2 and Λ3 are
mutually orthogonal.
Third, we characterize Λ⊥ using the following technical trick. Define
Λ∗3 =
{∫
hu{V u,H(ψ
∗)}dMT (u) : hu{V u,H(ψ
∗)} ∈ Rp
}
.
Because the tangent space Λ1⊕Λ2⊕Λ∗3 is that for a nonparametric model; i.e., a model that allows
for all densities of O, and because the tangent space for a nonparametric model is the entire Hilbert
space, we obtain that H = Λ1 ⊕ Λ2 ⊕ Λ∗3. Because Λ
⊥ must be orthogonal to Λ1 ⊕ Λ2, Λ⊥ consists
of all elements of Λ∗3 that are orthogonal to Λ3. It then suffices to find the projection of all elements
of Λ∗3,
∫
hu{V u,H(ψ
∗)}dMT (u), onto Λ⊥3 . To find the projection, we derive h
∗
u(V u) such that[∫
hu{V u,H(ψ
∗)}dMT (u)−
∫
h∗u(V u)dMT (u)
]
∈ Λ⊥3 .
20
Therefore, we have
E
(∫ [
hu{V u,H(ψ
∗)} − h∗u(V u)
]
dMT (u)×
∫
hu(V u)dMT (u)
)
= 0, (26)
for any hu(V u). It is important to note that by Assumption 6, MT (t) is a martingale with respect
to the filtration σ{V t,H(ψ∗)}. If P1(u) and P2(u) are locally bounded σ{V t,H(ψ∗)}-predictable
processes, then we have the following useful result:
E
{∫ t
0
P1(u)dMT (u)
∫ t
0
P2(u)dMT (u)
}
=
∫ t
0
P1(u)P2(u)λT (u | V u)YT (u)du. (27)
By (27), (26) becomes
E
(∫ [
hu{V u,H(ψ
∗)} − h∗u(V u)
]
hu(V u)λT (u | V u)YT (u)du
)
= E
(∫
E
([
hu{V u,H(ψ
∗)} − h∗u(V u)
]
YT (u) | V u
)
hu(V u)λT (u | V u)du
)
= 0,
for any hu(V u). Because hu(V u) is arbitrary, we obtain
E
([
hu{V u,H(ψ
∗)} − h∗u(V u)
]
YT (u) | V u
)
= 0. (28)
Solving (28) for h∗u(V u), we obtain
h∗u(V u) = E
[
hu{V u,H(ψ
∗)} | V u, T ≥ u
]
.
This completes the proof.
8.2 Proof of Theorem 2
For any B = B(F ), let
G = G(F ) =
∫ τ
0
[
E
{
BH˙u(ψ
∗) | V u, T = u
}
− E
{
BH˙u(ψ
∗) | V u, T ≥ u
}]
×
[
var
{
H(ψ∗) | V u, T ≥ u
}]−1 [
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u
}]
dMT (u).
To show
∏(
B | Λ⊥
)
= G, it is easy to see that G ∈ Λ⊥, so the remaining is to show that B−G ∈ Λ.
Toward this end, we show that for any G˜ = G˜(F ) =
∫ τ
0 c˜(V u)[H(ψ
∗) − E{H(ψ∗) | V u, T ≥
u}]YT (u)dMT (u) ∈ Λ
⊥, (B−G)⊥ G˜ or E{(B−G)G˜} = 0. We now verify E(BG˜) = E(GG˜) by the
following calculation.
First, by (27), we calculate
E
(
GG˜
)
= E
∫ τ
0
c˜(V u)[E{BH˙u(ψ
∗) | V u, T = u} − E{BH˙u(ψ
∗) | V u, T ≥ u}]
×[var{H(ψ∗) | V u, T ≥ u}]
−1[H(ψ∗)− E{H(ψ∗) | V u, T ≥ u}]
2
×λT (u | V u)YT (u)du
= E
∫ τ
0
c˜(V u)[E{BH˙u(ψ
∗) | V u, T = u} − E{BH˙u(ψ
∗) | V u, T ≥ u}]
×λT (u | V u)YT (u)du. (29)
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Second, we calculate
E
(
BG˜
)
= E
∫ τ
0
c˜(V u)B[H(ψ
∗)− E{H(ψ∗) | Lu, T ≥ u}]dMT (u)
= E
∫ τ
0
c˜(V u)BH˙u(ψ
∗)dNT (u)
−E
∫ τ
0
c˜(V u)BH˙u(ψ
∗)λT (u | V u)YT (u)du
= E
∫ τ
0
c˜(V u)[E{BH˙u(ψ
∗) | V u, T = u} − E{BH˙u(ψ
∗) | V u, T ≥ u}]
×λT (u | V u)YT (u)du, (30)
where the last equality follows because
E
∫ τ
0
c˜(V u)BH˙u(ψ
∗)dNT (u) = E
∫ τ
0
c˜(V u)E{BH˙u(ψ
∗) | V u, T}dNT (u)
= E
∫ τ
0
c˜(V u)E{BH˙u(ψ
∗) | V u, T = u}λT (u | V u)YT (u)du,
and
E
{∫ τ
0
c˜(V u)BH˙u(ψ
∗)λT (u | V u)YT (u)du
}
= E
[∫ τ
0
c˜(V u)E{BH˙u(ψ
∗) | V u, YT (u)}λT (u | V u)YT (u)du
]
= E
[∫ τ
0
c˜(V u)E{BH˙u(ψ
∗) | V u, T ≥ u}λT (u | V u)YT (u)du
]
.
Therefore, by (29) and (30), E(BG˜) = E(GG˜) for any G˜ ∈ Λ⊥, proving (11).
8.3 Proof of Theorem 3
The semiparametric efficient score is S∗eff(ψ
∗) =
∏(
Sψ | Λ
⊥
)
. By Theorem 2, we have
S∗eff(ψ
∗) =
∫ τ
0
[E{SψH˙u(ψ
∗) | V u, T = u} − E{SψH˙u(ψ
∗) | V u, T ≥ u}]
×[var{H(ψ∗) | V u, T ≥ u}]
−1[H(ψ∗)− E{H(ψ∗) | V u, T ≥ u}]dMT (u)
= −
∫ τ
0
[E{∂H˙u(ψ
∗)/∂ψ | V u, T = u} − E{∂H˙u(ψ
∗)/∂ψ | V u, T ≥ u}]
×[var{H(ψ∗) | V u, T ≥ u}]
−1[H(ψ∗)− E{H(ψ∗) | V u, T ≥ u}]dMT (u)
= −
∫ τ
0
E{∂H˙u(ψ
∗)/∂ψ | V u, T = u}[var{H(ψ
∗) | V u, T ≥ u}]
−1
×H(ψ∗)− E{H(ψ∗) | V u, T ≥ u}]dMT (u),
where the last equality follows by using the generalized information equality: because H˙u(ψ∗) =
H(ψ∗) − E{H(ψ∗) | V u, T ≥ u}, we have E{H˙u(ψ∗) | V u, T ≥ u} = 0. Take the derivative of
ψ at both sides, we have E{SψH˙u(ψ∗) | V u, T ≥ u} + E{∂H˙u(ψ∗)/∂ψ | V u, T ≥ u} = 0, or
equivalently E{SψH˙u(ψ∗) | V u, T ≥ u} = −E{∂H˙u(ψ∗)/∂ψ | V u, T ≥ u}. Similarly, noticing
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E{H(ψ∗) | V u, T ≥ u} = E{H(ψ
∗) | V u, T = u}, we have E{H˙u(ψ∗) | V u, T = u} = 0. Take the
derivative of ψ at both sides, we have E{SψH˙u(ψ∗) | V u, T = u}+E{∂H˙u(ψ∗)/∂ψ | V u, T = u} = 0,
or equivalently E{SψH˙u(ψ∗) | V u, T = u} = −E{∂H˙u(ψ∗)/∂ψ | V u, T = u}. Ignoring the negative
sign, the result in Theorem 3 follow.
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Supplementary material for
“Structural nested mean models with irregularly
spaced observations”
S1 Proofs
S1.1 Proof of (9)
First, we express
λT {t | V t, Y
(∞)} = lim
h→0
h−1P{t ≤ T < t+ h | V t, Y
(∞), T ≥ t}
= lim
h→0
h−1
f{Y (∞) | V t, t ≤ T < t+ h}P{t ≤ T < t+ h | V t, T ≥ t}
f{Y (∞) | V t, T ≥ t}
= lim
h→0
h−1
f{H(ψ∗) | V t, t ≤ T < t+ h}P{t ≤ T < t+ h | V t, T ≥ t}
f{H(ψ∗) | V t, T ≥ t}
= lim
h→0
h−1P{t ≤ T < t+ h | V t,H(ψ
∗), T ≥ t}
= λT {t | V t,H(ψ
∗)},
where the second equality follows by the Bayes rule, and the third equality follows by Model (7)
which implies that the distribution of {V t, Y (∞)} is the same as the distribution of {V t,H(ψ∗)}.
Second, by Assumption 6, λT {t | V t, Y (∞)} = λT (t | V t). Therefore, λT {t | V t,H(ψ∗)} = λT {t |
V t, Y
(∞)} = λT (t | V t).
S1.2 Proof of Theorem 4
We show that E{G(ψ∗;F, c)} = 0 in two cases.
First, if λT (t | V t) is correctly specified, under Assumption 6,MT (t) is a martingale with respect
to the filtration σ{V t,H(ψ∗)}. Because c(V u)[H(ψ∗)− E{H(ψ∗) | V u, T ≥ u}] is a σ{V t,H(ψ∗)}-
predictable process,
∫ t
0 c(V u)[H(ψ
∗) − E{H(ψ∗) | V u, T ≥ u}]dMT (u) is a martingale for t ≥ 0.
Therefore, E{G(ψ∗;F, c)} = 0.
Second, if E
{
H(ψ∗) | V u, T ≥ u
}
is correctly specified but λT (t | V t) is not necessarily correctly
specified, let λ∗T (t | V t) be the probability limit of the possibly misspecified model. We obtain
E
∫
c(V u)
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}] {
dNT (u)− λ
∗
T (u | V u)YT (u)du
}
= E
∫
c(V u)
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}] {
dNT (u)− λT (u | V u)YT (u)du
}
+E
∫
c(V u)
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}] {
λT (u | V u)− λ
∗
T (u | V u)
}
YT (u)du
= 0 + E
∫
c(V u)E
([
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
| V u, T ≥ u
)
(S1)
×
{
λT (u | V u)− λ
∗
T (u | V u)
}
YT (u)du
= 0 + E
∫
c(V u)× 0×
{
λT (u | V u)− λ
∗
T (u | V u)
}
YT (u)du = 0, (S2)
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where zero in (S1) follows because dMT (u) = dNT (u)− λT (u | V u)du is a martingale with respect
to the filtration σ{V t,H(ψ∗)}, and zero in (S2) follows because E
{
H(ψ∗) | V u, T ≥ u
}
is correctly
specified and therefore, E
{
H(ψ∗) | V u, T ≥ u;β
∗
}
= E
{
H(ψ∗) | V u, T ≥ u
}
.
S1.3 Proof of Theorem 5
We show that E
{
δCG(ψ
∗, β∗,M∗T ;F )/K
∗
C (τ | V τ )
}
= 0 in three cases.
First, under Scenarios (a), (b), and (c) listed in Table 1 when K∗C is correctly specified for KC ,
either E{H(ψ∗) | V u, T ≥ u;β∗} is correctly specified or M∗T is correctly specified for MT , we show
that (18) is an unbiased estimating equation. Under these scenarios, we have K∗C(τ | V τ ) = KC(τ |
V τ ). It suffices to show that
E
{
δC
KC
(
τ | V τ
)G(ψ∗, β∗,M∗T ;F )
}
= E
[
E
{
δC
KC
(
τ | V τ
)G(ψ∗, β∗,M∗T ;F ) | F
}]
= E
{
E(δC | F )
KC
(
τ | V τ
)G(ψ∗, β∗,M∗T ;F )
}
= E
[
E(δC | V τ )
KC
(
τ | V τ
)E{G(ψ∗, β∗,M∗T ;F ) | V τ}
]
,
where the third equality follows by Assumption 7, and the last equality follows by Theorem 4.
Second, under Scenarios (b) and (d) listed in Table 1 when E{H(ψ∗) | V u, T ≥ u;β∗} is correctly
specified, we have E{H(ψ∗) | V u, T ≥ u;β∗} = E{H(ψ∗) | V u, T ≥ u}. Also, under Assumption 6,
E
{
H(ψ∗) | V u, T ≥ u
}
= E
{
H(ψ∗) | V u
}
. Then, we have
E{G(ψ∗, β∗,M∗T ;F ) | V τ}
= E
{∫
c(V u)
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dM∗T (u) | V τ
}
=
∫
c(V u)E
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u
}
| V τ
]
E
{
dM∗T (u) | V τ
}
=
∫
c(V u)E
[
E
{
H(ψ∗) | V u
}
− E
{
H(ψ∗) | V u, T ≥ u
}
| V τ
]
E
{
dM∗T (u) | V τ
}
=
∫
c(V u)E
[
E
{
H(ψ∗) | V u, T ≥ u
}
− E
{
H(ψ∗) | V u, T ≥ u
}
| V τ
]
E
{
dM∗T (u) | V τ
}
= 0.
It follows that
E
{
δC
K∗C
(
τ | V τ
)G(ψ∗, β∗,M∗T ;F )
}
= E
[
E
{
δC
K∗C
(
τ | V τ
)G(ψ∗, β∗,M∗T ;F ) | F
}]
= E
[
KC
(
τ | V τ
)
K∗C
(
τ | V τ
)E{G(ψ∗, β∗,M∗T ;F ) | V τ}
]
= E
{
KC
(
τ | V τ
)
K∗C
(
τ | V τ
) × 0} = 0.
Third, under Scenario (e) listed in Table 1 when M∗T is correctly specified for MT , we have
E
{
dMT (u) | V u
}
= 0, (u > 0). (S3)
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Define κ(V u) = E
{
KC
(
τ | V τ
)
/K∗C
(
τ | V τ
)
| V u
}
for all u > 0. We show E
{
δCG(ψ
∗, β∗,MT ;F )/K
∗
C (τ | V τ )
}
=
0 by induction. Let ∆ > 0 be a small increment. We start with
E
{
δC
K∗C
(
τ | V τ
)G(ψ∗, β∗,MT ;F )}
= E
[
κ(V τ )
∫ τ
0
c(V u)
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dMT (u)
]
(S4)
= E
[
κ(V τ )E
{(∫ τ−∆
0
+
∫ τ
τ−∆
)
c(V u)
[
H(ψ∗)− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dMT (u) | V τ
}]
= E
[
E
{
κ(V τ ) | V τ−∆
}∫ τ−∆
0
c(V u)
[
E
{
H(ψ∗) | V u, T ≥ u
}
− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dMT (u)
]
+E
{
κ(V τ )
∫ τ
τ−∆
c(V u)
[
E
{
H(ψ∗) | V u, T ≥ u
}
− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dMT (u)
}
= E
{
κ(V τ−∆)
∫ τ−∆
0
c(V u)
[
E
{
H(ψ∗) | V u, T ≥ u
}
− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dMT (u)
}
+E
{
κ(V τ )c(V τ )
[
E
{
H(ψ∗) | V τ , T ≥ τ
}
− E
{
H(ψ∗) | V τ , T ≥ τ ;β
∗
}]
E
{
dMT (τ) | V τ
}}
= E
{[
κ(V τ−∆)
∫ τ−∆
0
c(V u)
[
E
{
H(ψ∗) | V u, T ≥ u
}
− E
{
H(ψ∗) | V u, T ≥ u;β
∗
}]
dMT (u)
]}
+ 0,(S5)
where 0 in the last equality follows by (S3). Note that (S5) is (S4) replacing τ by τ −∆. We then
repeat the same calculation for (S5) until τ −∆ reaches zero. The last step is to recognize that (S5)
with τ −∆ = 0 is zero. This completes the proof.
S1.4 Proof of Theorem 6
We assume the multiple robustness condition holds; i.e. either the potential outcome mean model
or the model for the treatment process is correctly specified, regardless the model for the censoring
process is correctly specified.
Taylor expansion of Pn
{
Φ(ψ̂, β̂, M̂T , K̂C ;F )
}
= 0 around ψ∗ leads to
0 = Pn
{
Φ(ψ̂, β̂, M̂T , K̂C ;F )
}
= Pn
{
Φ(ψ∗, β̂, M̂T , K̂C ;F )
}
+ Pn
{
∂Φ(ψ˜, β̂, M̂T , K̂C ;F )
∂ψT
}
(ψ̂ − ψ∗),
where ψ˜ is on the line segment between ψ̂ and ψ∗.
Under Assumption 9 (i) and (ii),
(Pn − P)
{
∂Φ(ψ˜, β̂, M̂T , K̂C ;F )
∂ψT
}
= (Pn − P)
{
∂Φ(ψ∗, β∗,M∗T ,K
∗
C ;F )
∂ψT
}
= op(n
−1/2),
and therefore,
Pn
{
∂Φ(ψ˜, β̂, M̂T , K̂C ;F )
∂ψT
}
= P
{
∂Φ(ψ˜, β̂, M̂T , K̂C ;F )
∂ψT
}
+ op(n
−1/2)
= A(ψ∗, β∗,M∗T ,K
∗
C) + op(n
−1/2).
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We then have
n1/2(ψ̂ − ψ∗) = {A(ψ∗, β∗,M∗T ,K
∗
C)}
−1 n1/2Pn
{
Φ(ψ∗, β̂, M̂T , K̂C ;F )
}
+ op(1). (S6)
Based on the multiple robustness, we have
P{Φ(ψ∗, β∗,M∗T ,K
∗
C ;F )} = 0. (S7)
To express (S6) further, based on (S7), we have
PnΦ(ψ
∗, β̂, M̂T , K̂C ;F ) = (Pn − P)Φ(ψ
∗, β̂, M̂T , K̂C ;F )
+ P
{
Φ(ψ∗, β̂, M̂T , K̂C ;F )− Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F )
}
+ PΦ(ψ∗, β∗,M∗T ,K
∗
C ;F ). (S8)
By Assumption 9 (i) and (ii), the first term in (28) becomes
(Pn − P)Φ(ψ
∗, β̂, M̂T , K̂C ;F ) = (Pn − P)Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + op(n
−1/2)
= PnΦ(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + op(n
−1/2). (S9)
By Assumption 9 (iv), the second term in (28) becomes
P
{
Φ(ψ∗, β̂, M̂T , K̂C ;F )− Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F )
}
= J(β̂, M̂T , K̂C)− J(β
∗,M∗T ,K
∗
C) + op(n
−1/2)
= J1(β̂)− J1(β
∗) + J2(M̂T )− J2(M
∗
T ) + J3(K̂C)− J3(M
∗
C) + op(n
−1/2)
= PnΦ1(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + PnΦ2(ψ
∗, β∗,M∗T ,K
∗
C ;F )
+PnΦ3(ψ
∗, β∗,M∗T ,K
∗
C ;F ). (S10)
Combining (S7)–(S10),
PnΦ(ψ
∗, β̂, M̂T , K̂C ;F ) = Pn{B˜(ψ
∗, β∗,M∗T ,K
∗
C ;F )},
where
B˜(ψ∗, β∗,M∗T ,K
∗
C ;F ) = Φ(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + Φ1(ψ
∗, β∗,M∗T ,K
∗
C ;F )
+Φ2(ψ
∗, β∗,M∗T ,K
∗
C ;F ) + Φ3(ψ
∗, β∗,M∗T ,K
∗
C ;F ).
As a result,
n1/2(ψ̂ − ψ∗) = n1/2PnΦ˜(ψ
∗, β∗,K∗V ,K
∗
C ;F ) + op(1), (S11)
where
Φ˜(ψ∗, β∗,M∗T ,K
∗
C ;F ) = {A(ψ
∗, β∗,M∗T ,K
∗
C)}
−1 B˜(ψ∗, β∗,M∗T ,K
∗
C ;F ).
We now consider the case when all nuisance models are correctly specified, i.e., E{H(ψ∗) |
V u, T ≥ u;β
∗} = E{H(ψ∗) | V u, T ≥ u}, M∗T =MT , and K
∗
C = KC .
Define the score functions: Sβ = Sβ{H(ψ∗), V u, T ≥ u}. Then, the tangent space for β is
Λ˜1 = {Sβ ∈ R
p : E(Sβ | V u, T ≥ u) = 0}. Following Tsiatis (2006), the nuisance tangent space for
the proportional hazards model (16) is
Λ˜2 =
{
Sα +
∫
h(u)dMT (u) : h(u) ∈ R
p
}
,
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Algorithm 1 Algorithm 1 for generating T according to a time-dependent proportional hazards
model
Step 1. Set k = 1.
Step 2. Generate a temporary time to treatment initiation, Ttemp,k, compatible with the hazard
function for the time interval [tk, tk+1), using the method of Bender et al. (2005); i.e., generate
u ∼Uniform[0, 1] and let Ttemp,k =− log(1− u)/{λT,0 exp(α∗1LTI + α
∗
2LTD,tk)}.
If Ttemp,k is contained within the first time interval [0, tk+1 − tk), then set T = Ttemp,k + tk;
else if Ttemp,k is not contained within the interval [0, tk+1 − tk), increase k by 1 and move to
the beginning of Step 2.
where
Sα :=
∫ {
WT (u, V u)−
E
[
WT (u, V u) exp
{
γTWT (u, V u)
}
YT (u)
]
E
[
exp
{
αTWT (u, V u)
}
YT (u)
] } dMT (u). (S12)
The nuisance tangent space for the proportional hazards model (19) is
Λ˜3 =
{
Sη +
∫
h(u)dMC(u) : h(u) ∈ R
p
}
,
where
Sη :=
∫ {
WC(u, V u)−
E
[
WC(u, V u) exp
{
ηTWC(u, V u)
}
YC(u)
]
E
[
exp
{
ηTWC(u, V u)
}
YC(u)
] }dMC(u). (S13)
Assuming that the treatment process and the censoring process can not jump at the same time
point, Λ˜1, Λ˜2, and Λ˜3 are mutually orthogonal to each other. Therefore, the nuisance tangent space
for β and the proportional hazards models (16) and (19) is Λ˜ = Λ˜1⊕Λ˜2⊕Λ˜3. The influence function
for ψ̂ is
B˜(ψ∗, β∗,MT ,KC ;F )
= Φ(ψ∗, β∗,MT ,KC ;F )−
∏{
Φ(ψ∗, β∗,MT ,KC ;F ) | Λ˜
}
= Φ(ψ∗, β∗,MT ,KC ;F )− E {Φ(ψ
∗, β∗,MT ,KC ;F )S
T
α}E (SαS
T
α)
−1 Sα
−E
{
Φ(ψ∗, β∗,MT ,KC ;F )S
T
η
}
E
(
SηS
T
η
)−1
Sη
+
∫
E
[
G(ψ∗, β∗,MT ;F ) exp
{
αTWT (u, V u)
}
δC/KC(τ | V τ )
]
E
[
exp
{
αTWT (u, V u)
}
YT (u)
] dMC(u)
+
∫
E
[
G(ψ∗, β∗,MT ;F ) exp
{
ηTWC(u, V u)
}
δC/KC(τ | V τ )
]
E
[
exp
{
ηTWC(u, V u)
}
YC(u)
] dMT (u). (S14)
S2 Details for the simulation study
First, Algorithm 1 specifies the steps for generating T according to a time-dependent proportional
hazards model. Second, we describe the nuisance models and their estimation. For c(V u), we
approximate E{(1, T )T(τ − T )I(T ≤ τ) | V u, T ≥ u} by P̂ (T ≤ τ | V u, T ≥ u)× Ê{(1, T )T(τ − T ) |
V u, u ≤ T ≤ τ}. We describe the details for fitting below:
(a) P̂ (T ≤ τ | V u, T ≥ u) is the predicted value from a logistic regression model of I(T ≤ τ)
against u, LTI , LTD,u, and all interactions of these terms, restricted to subjects with T ≥ u.
(b) Ê(τ −T | V u, u ≤ T ≤ τ) is the predicted value from a linear regression model of τ −T against
u, LTI , LTD,u, and all interactions of these terms, restricted to subjects with u ≤ T ≤ τ .
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Table 5: Fitted time-dependent proportional hazards models for the time to treatment initiation
and the time to censoring
time to treatment initiation time to censoring
Est SE p-val Est SE p-val
male -0.35 0.161 0.03 * 0.21 0.159 0.19
age 0.01 0.003 0.08 . -0.02 0.004 0.00 ***
white non-hispanic 0.12 0.066 0.07 . 0.02 0.077 0.77
injdrug -0.50 0.180 0.01 ** 0.74 0.156 0.00 ***
CD41/2u -0.06 0.007 0.00 *** -0.03 0.007 0.00 ***
lvlu -0.14 0.013 0.00 *** 0.04 0.016 0.02 *
days from last visitu -0.03 0.002 0.00 *** -0.01 0.001 0.00 ***
first visitu -3.06 0.111 0.00 *** -1.24 0.231 0.00 ***
second visitu -0.04 0.081 0.61 0.68 0.178 0.00 ***
Treatedu – – – -0.15 0.102 0.15
Signif. codes: 0 ’***’ 0.001 ’**’ 0.01 ’*’ 0.05 ’.’
(c)Ê{T (τ − T ) | V u, u ≤ T ≤ τ} is the predicted value from a linear regression model of T (τ − T )
against u, LTI , LTD,u, and all interactions of these terms, restricted to subjects with u ≤ T ≤
τ .
(d) E{H(ψ̂p) | V u, T ≥ u; β̂} by a linear regression model of H(ψ̂p) against u, LTI , LTD,u, and all
interactions of these terms, restricted to subjects with T ≥ u.
S3 Nuisance models and fitting results in the application
We describe the nuisance models and fitting results for the AIEDRP database.
(a) The model for the censoring process (KC) is a time-dependent proportional hazards model
adjusting for age at infection (age), male, white non-Hispanic race (race), injection drug
ever/never (injdrug), square root of current CD4 count (CD41/2u ), log viral load (lvlu), and
whether a patient had initiated HAART (Treatedu).
(b) The model for the treatment process (MT ) is a time-dependent proportional hazards model
adjusting for age, male, race, injdrug, CD41/2u , lvlu, number of days since the last visit (days
from last visitu), whether the visit is the first visit (first visitu), whether the visit is the second
visit (second visitu).
(c) The outcome model E{H(ψ̂p) | V u, T ≥ u;β} is a linear regression model where the covariates
include age, male, race, injdrug, CD4u, lvlu, CD4
3/4
u (τ −u), CD4
3/4
u × (τ −u)×age, CD4
3/4
u ×
(τ − u)×male, CD43/4u × (τ − u)×race, CD4
3/4
u × (τ − u)×injdrug, CD4
3/4
u × (τ − u)×lvlu,
CD4slopeu measured, CD4slopeu × (τ − u)1/2 I(u ≤ 6)(6 − u), and I(u ≤ 6)(36 − u2).
(d) Other nuisance models E(τ−T | Lu, T ≥ u) and E{T (τ−T ) | Lu, T ≥ u)} are linear regression
models where the covariates include u, (τ − u), male×(τ − u), age×(τ − u), race×(τ − u),
injdrug×(τ−u), CD41/2u ×(τ−u), lvlu×(τ−u), days from last visitu×(τ−u), first visitu×(τ−u),
second visitu × (τ − u).
Table 5 reports the fitted time-dependent proportional hazards models for the time to treatment
initiation and the time to censoring. The results suggest that the covariates are important for
predicting the time to treatment initiation and the time to censoring.
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